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ABSTRACT
Objective: To determine the ocular and systemic factors associated with neovascular glaucoma
(NVG) in an African population.
Design: Hospital based cross sectional study.
Setting: Eye clinic, Department of Ophthalmology, University College Hospital, Ibadan, Nigeria.
Subjects: Sixty one consecutive patients with clinical diagnosis of NVG seen between January
1995 and December 1999 had a complete ocular evaluation.
Results: Among the 61 subjects studied with an identifiable aetiological factor presumably causing
neovascular glaucoma, 82% had associated posterior segment diseases producing ischaemia. These
were retinal venous obstruction (78.7%), retinal arterial occlusion (1.6%). Those with no identifiable
vaso-occlusive disease had couching (11.5%), aphakia with vitreous loss (3.3%) and chronic uveitis
(1.6%). Systemic arterial hypertension was present in 62.3% while diabetes mellitus was present
in only 8.3% of the subjects studied. Chronic uveitis and penetrating eye injury were infrequently
diagnosed. Chronic open angle glaucoma was present in the other eye of 37.7% of subjects.
Neovascular glaucoma was unilateral in 95.1% of subjects. 84.4% of affected eyes were blind on
presentation. Males outnumbered females among subjects with NVG above 40 years, while females
outnumbered males in the subjects below 40 years of age. Eyes of that were couched constitute a
significant proportion of subjects with neovascular glaucoma.
Conclusion: Medical conditions such as systemic hypertension, diabetes and ocular conditions
like retinal vein, retinal artery occlusion, couching and glaucoma were associated with NVG. Most
of these ocular and systemic associations should be identified early and treated to prevent
neovascular glaucoma in the other eye of the subject.
INTRODUCTION
Blindness from primary and secondary glaucoma
have been little addressed in most developing
countries. The slowly progressive blindness from
primary open angle glaucoma has received slightly
more attention than the secondary glaucomas.
Neovascular glaucoma (NVG) is such type of
secondary glaucoma, and it results from many
disease processes that cause ischaemia to the eye.
The fact that neovascular glaucoma frequently
follows retinal vein occlusion is well known (1-8).
Other aetiological associations with NVG include
diabetic retinopathy, central retinal artery
occlusions, ocular inflammation, injury and
intraocular tumours (3,6,7).
Neovascular glaucoma carries a guarded
prognosis. Prognosis is dependent on the degree of
the resulting ischaemia and early treatment of NVG.
Treatment of the underlying ocular and systemic
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diseases may reduce the occurrence in the other eye
(8-11).
In developing countries especially, where there
are delays in diagnosis or non-availability of
appropriate equipments for the management, NVG
is a potentially devastating disease. It cannot only
lead to loss of vision but of the globe itself.
It has been recognised that racial and geographic
variations occur in the incidence and mortality from
ischaemic conditions affecting the brain such as
cerebrovascular diseases (CVD) which is providing
a key to understanding the risk factors for CVD (9).
There is paucity of information on NVG which is an
ocular ischaemic condition in Africans, this paucity
of information however does not allow comparison
of risk factors for NVG between Africans and other
races.
This study aims to determine the demographic
characteristics, aetiological associations of NVG in
African subjects presenting with neovascular
glaucoma in a tertiary hospital in South Western
Nigeria.
MATERIALS AND METHODS
A study of patients who primarily presented with
neovascular glaucoma (NVG) to the Eye Clinic of
the University College Hospital (UCH), Ibadan,
Nigeria between January 1995 and December 1999
was carried out. Diagnosis of NVG was made based
on clinical assessments which were the observation
of any of the following features, optic nerve damage
associated with (a) the presence of vessels or
capillaries on the iris, pupil margin under slit lamp
magnification or at the anterior chamber angle with
gonioscopy with (b) elevated intraocular pressure
(lOP) higher than 21 mmHg. (c) This could be
accompanied by acute, severe pain, headache,
photophobia, reduced vision, conjunctival injection
and corneal oedema with or without hyphaema.
Each patient had a complete ophthalmological
assessment including visual acuity, slit lamp
examination, gonioscopy, ophthalmoscopy when
possible and IOP measurements.
The demographic characteristics of the patients
were noted. All patients had blood pressure
measurements and urinalysis for sugar and protein.
Hypertension was defined as systolic blood
pressure (SBP) greater than 140 mmHg and/or
diastolic blood pressure (DBP) 90 mmHg and over,
or if patient was already receiving anti-
hypertensive medications. Diabetes Mellitus was
diagnosed if the patient had glycosuria or was on
medication for diabetes. Chronic glaucoma was
diagnosed in the other eye when there was optic
disc cupping greater than 0.5 mmHg, visual field
defects with or without intraocular pressure greater
than 21 mmHg. Diagnosis of vein occlusions,
arterial occlusions were made from fundoscopic
features. Statistical analyses were performed using
the chi-square test.
RESULTS
Sixty six patients were diagnosed to have NVG out
of a total of 16,500 constituting 0.4% of all new out
patient attendance to the eye clinic during the period
under review. This represented 1.0% of all
glaucomas seen. Five subjects with incomplete
information were excluded from data analysis. Of
the remaining sixty one subjects, thirty two subjects
(52.5%) were males. Mean age at presentation was
59.2 years [SD 12.7 years]. Age range was 31-84
years, four patients were under 40 years of age.
Bilateral NVG occurred in three subjects (4.9%) while
unilateral NVG occurred in 58 (95.1%) of the
subjects. The right eye and left eyes were affected
almost equally, right eye was affected in 50.8% of
cases. Among the subjects aged 40-79 years, males
with NVG outnumbered females while among the
subjects 30-39 years and those aged 80 years and
above, females outnumbered males (Table 1).
The main presumed aetiological factor associated
with NVG in the subjects studied was retinal vein
occlusion occurring in 48 (78.7%) of the subjects. Of
these, central retinal vein occlusion accounted for
59.0%, hemicentral retinal vein occlusion (HCRVO)
16.4%, branch retinal vein occlusion (BRVO) 3.3%,
central retinal artery occlusion (CRAO) 1.6%, diabetic
retinopathy was 1.6%. Others were ocular
inflammation which were associated with couching
(11.5%), uveitis with retinal detachment (1.6%)
aphakia with vitreous loss (3.3%) and penetrating eye
injury (1.6%) (Table 2). Of the three subjects who had
bilateral NVG, one subject had DR while the other
two had systemic hypertension.
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Table 2
Proportion of NVG subjects with presumed aetiological factors
No of cases
Presumed aetiological All HT DM Glaucoma
Factor No. (%) No. (%) No. (%) No. (%)
Retinal venous occlusion 48 78.7 32 66.7 4 8.3 16 33.3
Central 36 59.0 24 66.7 3  8.3 10 27.8
Hemispheric 10 16.4 4 40 - 4 40
Branch 2 3.3 2 100 - 2 100
Diabetic retinopathy 1 1.6 1 100 1  100 -




Chronic Uveitis 1 1.6
Penetrating eye injury 1 1.6
Total 61
Table 1
Demographic and clinical characteristics of subjects with NVG
All CRVO  HCRVO BRVO CRAO Diabetic  Others
Retinopathy
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Characteristics
Total 61 100 36 59.0 10 16.4 2 3.3 1 1.6 1 1.6 11 18.0
Age (years)
<40 4 6.6 3 8.3 - - - - - 1
40–49 11 18.0 5 13.9 2 20 - - - 4
50–59 11 18.0 5 13.9 4 40.0 1 - - 1
60–69 20 32.8 14 38.9 1 10.0 1 1 1 2
70–79 11 18.0 7 19.7 3 30.0 1 - - 1
>80 4 6.6 2 5.6           - - - - 2
Total 61 100 36 -           10 2 1 1 -
Mean age 59.2 59.2 59.5 61.0 - - 55.3
(years)
Sex
Male 32 52.5           18            6 1 1 - 6
Female 29 47.5           18           4 1 - 1  5
Presenting
Visual acuity (VA)
%VA ≥ 3/60           54           36            7  - 1 1  9
% Established          37.7%             26.3%           33.3% 44.4% - - 66.7%
glaucoma in
other eye
% Severe                   62.3%             64.9%            66.7% 33.3% 100% -
hypertension
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The predominant associated systemic factor in
subjects who had retinal vascular occlusion were
systemic hypertension in 38(62.3%) subjects,
occurring predominantly in subjects with CRVO (24
out of 36), HCRVO (4 out of 10) BRVO (two out of
two), CRAO in one subject.
Four subjects had diabetes mellitus. Of these,
one had proliferative diabetic retinopathy; the other
three subjects had central retinal vein occlusion and
had systemic hypertension.
Ocular inflammation was identified as the
aetiological factor associated with NVG. This was
found in only one (1.6%) subjects. The ocular
inflammation was associated with a retina
detachment in that subject. Seven (11.5%) subjects
had couching (a local method of dislocating the lens
into the vitreous to treat blindness), two (3.3%) had
intracapsular cataract extraction but with vitreous
loss. Only one subject had a penetrating eye injury.
Chronic glaucoma was newly diagnosed in the
other eye in 23 (37.7%) subjects with NVG. Of these
23 subjects who had chronic glaucoma in their other
eye, 16(26.2%) have had retinal vein occlusion while
seven (11.5%) had couching done. Among these
sixteen subjects the chronic glaucoma in their other
eye was the open angles type in all cases.
There was visual impairment and severe visual
impairment (visual acuity worse than 6/18 and not
less than 3/60) at presentation in 10 (15.6%) eyes
with NVG, while 54 (84.4%) of affected eyes were
blind (visual acuity < 3/60) at presentation.
Blindness at presentation occurred in 36 (92.3%) eyes
with CRVO, seven (70%) eyes with HCRV, one eye
with CRAO, one eye with diabetic retinopathy and
in nine out of eleven eyes who had either couching,
uveitis or injury.
DISCUSSION
Retinal vein occlusion was the leading ocular
aetiological factor associated with NVG in this series
of Nigerian African subjects. This finding agrees
with several other clinical studies done in
Caucasians (1-9). Chronic glaucoma was newly
diagnosed in the other eye in more than a third of
all subjects who had NVG.
Systemic arterial hypertension was the most
frequent systemic disorder noted in subjects with
NVG in this series. The diagnosis was made by
clinical history and blood pressure measurement at
the time of presentation in about two thirds of the
subjects. The prevalence of hypertension in these
subjects is much higher than the prevalence of
hypertension in an age-matched general population,
(12,13) though the effect of selection bias might
contribute to this.
Unlike other studies, (8) diabetic retinopathy
(DR) was not a major associated factor with NVG in
this population. DR was found in one subject and
diabetes mellitus was a systemic disease found in
only four subjects with NVG. The other three
subjects, who had diabetes mellitus had no DR but
had hypertension which was the presumed systemic
cause of CRVO in their eyes. It is possible that
diabetes mellitus was under diagnosed in these
series as the diagnosis was based on urinalysis and
clinical history alone. A glucose tolerance test might
have made the number of subjects with diabetes
mellitus higher.
Ocular inflammation was an infrequently
associated condition leading to NVG unlike the
findings by Hoskins (1). However, there might have
been an under representation of ocular inflammation
in subjects with NVG in this series. 11.5% subjects
who presented with NVG had couching done.
Couching was done to treat blindness in the
population studied. The association between
couching and NVG had not been previously
reported. Most of the subjects who had couching also
had glaucoma in their other eye. A high proportion
of these subjects had systemic hypertension as well.
Eyes that were couched could also have had
inflammation. In eyes that were couched, it is
therefore difficult to separate the relative importance
of hypertension, glaucoma and inflammation in the
pathogenesis of ocular neovascularisation. It could
be that neovascularisation preceeded inflammation
or vice versa. It is known that eyes with NVG can
develop anterior chamber inflammation as a result
of leaking vessels. Therefore in couched eyes,
multiple factors such as inflammation, high
intraocular pressure or even arterial vascular
occlusion may interplay to cause NVG. Further
studies are needed to evaluate the mechanism of
ocular neovascularisation in a couched eye.
Retina arterial occlusion might have been under
diagnosed in this series without concomitant arterial
and venous obstruction can occur in an eye (7,12).
While venous obstruction could be diagnosed more
easily by fundoscopy, arterial obstruction may
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require angiographic studies. The only subject
whose diagnosis was CRAO in this series had severe
hypertension.
Arteriosclerosis in hypertension have been
suggested to be a major underlying factor causing
vein occlusion by compression of veins either at the
optic nerve head or on the retina (5). And in Africans,
hypertensive retinopathy was found in 70% of 350
Nigerians with hypertension (14). In blacks,
hypertension presents with higher pressures. Low
socioeconomic status and poor access to medical
care, poor compliance to therapy, all contribute to
poor prognosis and increased complications among
blacks (12,13).
The relative low number of subjects with
diabetes mellitus (DM) may reflect the relative
higher prevalence of hypertension than that of DM
in the general population (15), or may suggest a
lower prevalence of ischaemic retinal diseases in the
diabetic population in Nigerian Africans.
Among the 61 subjects in this study with an
identifiable aetiological factor presumably causing
NVG, 50(82%) had associated posterior segment
disease causing ischaemia. This was mainly retina
venous obstruction (78.7%). Those with no
identifiable vaso-occlusive disease were two (3.3%)
with aphakia with vitreous wick syndrome, chronic
uveitis one (1.6%) and couching seven (11.5%) and
an eye with penetrating eye injury.
The subjects who presented with NVG in this
series were more likely to have had ischaemic CRVO.
NVG rarely results from non-ischaemic vascular
occlusion (3,4,11) Neovascular glaucoma is known
to develop in 8% of all CRVO, and 67-82% of
ischaemic CRVO (3,4,10-12). The high prevalence of
hypertension in these subjects suggest the condition
to be a predisposing systemic factor associated with
CRVO in this series.
However, the subjects studied might have had
other diseases causing hyperviscosity. These were
investigated. It is interesting however that no
subject in this series had sickle cell disease even
when the prevalence of sickle cell disease in the
population is high (16). NVG has been reported to
occur infrequently in subjects with proliferative
sickle retinopathy (9). It has been suggested that
the area of peripheral retinal ischaemia perhaps is
smaller and hence less likely to elicit production
of angiogenesis factor required to produce NVG
(9,17).
The age and sex distribution of subjects in these
series are similar to those seen with vascular
occlusive diseases (6-7,16,17). The relative difference
in sex ratio in subjects below 40 years and those
above 40 years is noteworthy. There is a suggestion
from this study that the associated factors with NVG
in young subjects may be related to gender.
That 84.4% of eyes were blind on presentation
underscores the severity of NVG. In developing
countries, treatment of NVG are not readily available
hence the loss of vision and sometimes the globe.
There is therefore a need to tackle these known
factors especially hypertension.
CONCLUSION
In this African population, medical conditions like
hypertension and ocular conditions like glaucoma
and couching were important associations found in
subjects presenting with NVG. Both conditions were
associated with retina vascular occlusive diseases.
Diabetes Mellitus was not frequently associated
with the condition. The role of other conditions
causing hyperviscosity in Africans need to be
investigated.
NVG was a primary presentation of chronic
glaucoma. Failure to diagnose this may lead to loss
of vision in the other eye either from glaucomatous
optic atrophy or a second NVG in the other eye.
Identification of these medical and ocular
conditions and their treatment should reduce the
prevalence of NVG and its consequences.
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